Clinical Trial Update: Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer [Phase 3]

View source ↗

Summary

This is an update on a Phase 3 clinical trial evaluating cancer stem cell assay-directed chemotherapy for recurrent platinum-resistant ovarian cancer. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Cordgenics, LLC | Conditions: Recurrent Ovarian Carcinoma, Platinum-resistant Ovarian Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING